http://www.newstin.com/us/CELL_GENESYS Organizing the News Copyright © 2006 I2S a.s. Copyright © 2006 I2S a.s. http://www.newstin.com/tag/us/79968607 DALLAS, Texas – Beacon Equity Research announces the release of a Trade Alerts covering market movers: Dendreon Corp. (Nasdaq: DNDN), Spansion Inc. (Nasdaq: SPSN), Sonus Networks Inc. (Nasdaq: SONS), Cell Genesys Inc. (Nasdaq:... Wed, 08 Oct 2008 07:00:00 GMT http://www.newstin.com/tag/us/79968607 2008-10-08T07:00:00Z http://www.newstin.com/tag/us/79982418 Teaser: Investors didn't seem to know what to make of Dendreon 's (Nasdaq: DNDN) announcement of interim data from its phase 3 trial -- called IMPACT -- for its Provenge prostate-cancer treatment yesterday. The company's stock... Wed, 08 Oct 2008 09:02:23 GMT http://www.newstin.com/tag/us/79982418 2008-10-08T09:02:23Z http://www.newstin.com/tag/us/79681635 Interim Phase III data showed that Provenge cut the risk of death vs. placebo, sending shares of Dendreon Corp. soaring 33.3 percent, even though results failed to meet the prespecified endpoint that would have allowed the firm... Mon, 06 Oct 2008 20:22:18 GMT http://www.newstin.com/tag/us/79681635 2008-10-06T20:22:18Z http://www.newstin.com/tag/us/78810330 Teaser: The occasional shower of pennies from heaven might do our bank accounts some good, but we Fools can't say the same for penny stocks. Because the world of penny stocks is often full of manipulation and deceit, investors... Thu, 02 Oct 2008 05:29:38 GMT http://www.newstin.com/tag/us/78810330 2008-10-02T05:29:38Z http://www.newstin.com/tag/us/78557055 Thursday August 28, 3:11 pm ET Cell Genesys recovers part of Wednesday's loss, analyst still expects success for GVAX NEW YORK (AP) -- Shares of Cell Genesys Inc. made a modest recovery Thursday, a day after the company stopped... Wed, 01 Oct 2008 11:19:01 GMT http://www.newstin.com/tag/us/78557055 2008-10-01T11:19:01Z http://www.newstin.com/tag/us/77652733 Toni Clarke BOSTON (Reuters) - Small biotechnology companies with cash but failed or floundering products are in hot demand as partners for companies that are unable to raise money in the capital markets. One of them is... Thu, 25 Sep 2008 13:18:55 GMT http://www.newstin.com/tag/us/77652733 2008-09-25T13:18:55Z http://www.newstin.com/tag/us/76863821 SOUTH SAN FRANCISCO, Calif.----Cell Genesys, Inc. today announced that the U.S. Food and Drug Administration has, as expected, placed a partial clinical hold on the GVAX Phase 3 program for prostate cancer as a result... Mon, 15 Sep 2008 22:17:12 GMT http://www.newstin.com/tag/us/76863821 2008-09-15T22:17:12Z http://www.newstin.com/tag/us/76647704 SOUTH SAN FRANCISCO, Calif. - Biotechnology company Cell Genesys Inc. said Thursday the Food and Drug Administration placed a partial clinical hold on an ongoing late-stage study for the GVAX prostate cancer vaccine. The... Thu, 11 Sep 2008 15:27:25 GMT http://www.newstin.com/tag/us/76647704 2008-09-11T15:27:25Z http://www.newstin.com/tag/us/76330047 Top Searches Bio-IT World CHI's Network To have your event featured here, contact Big Pharma’s Road to Enlight(enment) Three big pharma invest in a bold new model for emerging technology development. By Kevin Davies and... Sat, 06 Sep 2008 00:23:00 GMT http://www.newstin.com/tag/us/76330047 2008-09-06T00:23:00Z http://www.newstin.com/tag/us/76150457 NEW YORK, NY (MARKET WIRE) BioCentury Publications, Inc. and Thomson Reuters announced that the robust lineup of companies presenting at the 15th Annual NewsMakers in the Biotech Industry conference has led the current... Wed, 03 Sep 2008 12:00:00 GMT http://www.newstin.com/tag/us/76150457 2008-09-03T12:00:00Z